A case of Beh‡et's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab

被引：94
|
作者：
Hirano, Toru [1 ]
Ohguro, Nobuyuki [2 ]
Hohki, Satoshi [3 ]
Hagihara, Keisuke [1 ]
Shima, Yoshihito [1 ]
Narazaki, Masashi [1 ]
Ogata, Atsushi [1 ]
Yoshizaki, Kazuyuki [4 ]
Kumanogoh, Atsushi [1 ]
Kishimoto, Tadamitsu [5 ]
Tanaka, Toshio [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan
[2] Osaka Koseinenkin Hosp, Dept Ophthalmol, Osaka, Japan
[3] Toyama Univ, Dept Ophthalmol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan
[4] Osaka Univ, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan
[5] Osaka Univ, Lab Immune Regulat, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan
来源：
MODERN RHEUMATOLOGY | 2012年 / 22卷 / 02期
关键词：
Behcet's disease; IL-6; Tocilizumab; GENOME-WIDE ASSOCIATION; BEHCETS-DISEASE; CEREBROSPINAL-FLUID; INTERLEUKIN-6; IL23R-IL12RB2; GENERATION; THERAPY; CELLS; IL10;
D O I：
10.1007/s10165-011-0497-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 47-year-old female patient with Beh double dagger et's disease had been treated with colchicine, prednisolone, cyclosporine A, and infliximab. Because she relapsed, however, treatment with tocilizumab, a humanized anti-interleukin 6 receptor antibody, was started. This treatment suppressed the patient's clinical manifestations, including ocular attacks, for 1 year and improved her visual acuity. This experience indicates that tocilizumab may constitute a therapeutic option for refractory Beh double dagger et's disease.
引用
收藏
页码：298 / 302
页数：5
相关论文
共 50 条
  • [31] Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody
    Nishimoto, Norihiro
    Nakahara, Hideko
    Yoshio-Hoshino, Naoko
    Mima, Toru
    ARTHRITIS AND RHEUMATISM, 2008, 58 (04): : 1197 - 1200
  • [32] Paradoxical mucocutaneous flare in a case of Beh‡et's disease treated with tocilizumab
    Cantarini, Luca
    Lopalco, Giuseppe
    Vitale, Antonio
    Coladonato, Laura
    Rigante, Donato
    Lucherini, Orso Maria
    Lapadula, Giovanni
    Iannone, Florenzo
    CLINICAL RHEUMATOLOGY, 2015, 34 (06) : 1141 - 1143
  • [33] Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab
    Luca Cantarini
    Giuseppe Lopalco
    Antonio Vitale
    Laura Coladonato
    Donato Rigante
    Orso Maria Lucherini
    Giovanni Lapadula
    Florenzo Iannone
    Clinical Rheumatology, 2015, 34 : 1141 - 1143
  • [34] Successful Treatment of a Mesangial Proliferative Glomerulonephritis with Interstitial Nephritis Associated with Castleman's Disease by an Anti-interleukin-6 Receptor Antibody (Tocilizumab)
    Otani, Naoko
    Morishita, Yoshiyuki
    Oh, Iekuni
    Saito, Osamu
    Takemoto, Fumi
    Muto, Shigeaki
    Kusano, Eiji
    INTERNAL MEDICINE, 2012, 51 (11) : 1375 - 1378
  • [35] Therapeutic uses of anti-interleukin-6 receptor antibody
    Kang, Sujin
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (01) : 21 - 29
  • [36] Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis
    Hirabayashi, Yasuhiko
    MODERN RHEUMATOLOGY, 2021, 31 (01) : 70 - 79
  • [37] Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
    Kawashiri, Shin-ya
    Kawakami, Atsushi
    Yamasaki, Satoshi
    Imazato, Takahiro
    Iwamoto, Naoki
    Fujikawa, Keita
    Aramaki, Toshiyuki
    Tamai, Mami
    Nakamura, Hideki
    Ida, Hiroaki
    Origuchi, Tomoki
    Ueki, Yukitaka
    Eguchi, Katsumi
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (04) : 451 - 456
  • [38] Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis
    Kawai, M.
    Hagihara, K.
    Hirano, T.
    Shima, Y.
    Kuwahara, Y.
    Arimitsu, J.
    Narazaki, M.
    Ogata, A.
    Kawase, I.
    Kishimoto, T.
    Tanaka, T.
    RHEUMATOLOGY, 2009, 48 (03) : 318 - 319
  • [39] Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
    Shin-ya Kawashiri
    Atsushi Kawakami
    Satoshi Yamasaki
    Takahiro Imazato
    Naoki Iwamoto
    Keita Fujikawa
    Toshiyuki Aramaki
    Mami Tamai
    Hideki Nakamura
    Hiroaki Ida
    Tomoki Origuchi
    Yukitaka Ueki
    Katsumi Eguchi
    Rheumatology International, 2011, 31 : 451 - 456
  • [40] Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy
    Yuzuriha, Akinori
    Saitoh, Takayuki
    Koiso, Hiromi
    Mitsui, Takeki
    Uchiumi, Hideki
    Yokohama, Akihiko
    Handa, Hiroshi
    Kojima, Masaru
    Tsukamoto, Norifumi
    Karaswa, Masamitsu
    Murakami, Hirokazu
    Nojima, Yoshihisa
    ACTA HAEMATOLOGICA, 2011, 126 (03) : 147 - 150
12345